Padraic O'Malley, MSc, MD, FRCSC : Research

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.

Investigators

Padraic O'Malley, Tarik Benidir

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement…

Investigator

Padraic O'Malley

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

During partial nephrectomy surgery, efforts at minimizing ischemia while maximizing renal parenchymal volume are desirable to preserve renal function1,2. Not only clamping of the hilum but the renorrhaphy portion of the procedure also can have a…

Investigator

Padraic O'Malley

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All